XML 65 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1

Earnings (Loss) per Share (Tables)

12 Months Ended

Dec. 31, 2018

Schedule of Earnings per Share

The net income attributable to Teva and the weighted average number of ordinary shares used in computation of basic and diluted earnings per share for the years ended December 31, 2018, 2017 and 2016 are as follows:

		2018				2017				2016
		(U.S. $ in millions, except share data)
Net income (loss) used for the computation of diluted earnings per share		$	(2,399	)		$	(16,525	)		$	68
Weighted average number of shares used in the computation of basic earnings per share			1,021				1,016				955
Add:
Additional shares from the assumed exercise of employee stock options and unvested RSUs			—				—				3
Weighted average number of additional shares issued upon the assumed conversion of convertible senior debentures			—				—				3
Weighted average number of shares used in the computation of diluted earnings per share			1,021				1,016				961

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration